According to Apyx Medical's latest financial reports the company's current EPS (TTM) is -HK$3.65. In 2022 the company made an earnings per share (EPS) of -HK$5.20 a decrease over its 2021 EPS that were of -HK$3.41.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -HK$3.68 | -29.14% |
2022 | -HK$5.20 | 52.27% |
2021 | -HK$3.41 | 25.71% |
2020 | -HK$2.72 | -40.68% |
2019 | -HK$4.58 | -131.05% |
2018 | HK$14.74 | -1287.5% |
2017 | -HK$1.24 | 6.67% |
2016 | -HK$1.16 | -128.85% |
2015 | HK$4.03 | -150.57% |
2014 | -HK$7.98 | 163.68% |
2013 | -HK$3.03 | -1084.77% |
2012 | HK$0.31 | 1006.54% |
2011 | HK$0.02776 | -103.98% |
2010 | -HK$0.70 | -325% |
2009 | HK$0.31 | -66.67% |
2008 | HK$0.93 | -20% |
2007 | HK$1.16 | -21.05% |
2006 | HK$1.47 | 533.33% |
2005 | HK$0.23 | -72.73% |
2004 | HK$0.85 | 120% |
2003 | HK$0.39 | -243.32% |
2002 | -HK$0.27 | -168.41% |
2001 | HK$0.40 | 2% |
2000 | HK$0.39 |